Jacobson KA - Search Results

1

Genetic and functional modulation by agonist MRS5698 and allosteric enhancer LUF6000 at the native A₃ adenosine receptor in HL-60 cells.

Gao ZG, Chen W, Gao RR, Li J, Tosh DK, Hanover JA, Jacobson KA. Gao ZG, et al. Among authors: jacobson ka. Purinergic Signal. 2024 Feb 28. doi: 10.1007/s11302-024-09992-z. Online ahead of print. Purinergic Signal. 2024. PMID: 38416332

2

Editorial: Small molecules and biologics for future purinergic therapeutics.

Jacobson KA, Salvemini D. Jacobson KA, et al. Purinergic Signal. 2023 Sep;19(3):465-466. doi: 10.1007/s11302-023-09964-9. Purinergic Signal. 2023. PMID: 37676356 Free PMC article.

3

Membrane mimetic-dependence of GPCR energy landscapes.

Thakur N, Ray AP, Jin B, Afsharian NP, Lyman E, Gao ZG, Jacobson KA, Eddy MT. Thakur N, et al. Among authors: jacobson ka. Structure. 2024 May 2;32(5):523-535.e5. doi: 10.1016/j.str.2024.01.013. Epub 2024 Feb 23. Structure. 2024. PMID: 38401537

4

Machine learning-aided search for ligands of P2Y₆ and other P2Y receptors.

Puhl AC, Lewicki SA, Gao ZG, Pramanik A, Makarov V, Ekins S, Jacobson KA. Puhl AC, et al. Among authors: jacobson ka. Purinergic Signal. 2024 Mar 25. doi: 10.1007/s11302-024-10003-4. Online ahead of print. Purinergic Signal. 2024. PMID: 38526670

5

Terpenes from Cannabis sativa induce antinociception in a mouse model of chronic neuropathic pain via activation of adenosine A2A receptors.

Schwarz AM, Keresztes A, Bui T, Hecksel R, Peña A, Lent B, Gao ZG, Gamez-Rivera M, Seekins CA, Chou K, Appel TL, Jacobson KA, Al-Obeidi FA, Streicher JM. Schwarz AM, et al. Among authors: jacobson ka. Pain. 2024 May 2. doi: 10.1097/j.pain.0000000000003265. Online ahead of print. Pain. 2024. PMID: 38709489

6

Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH.

Kaszas K, Keller JM, Coddou C, Mishra SK, Hoon MA, Stojilkovic S, Jacobson KA, Iadarola MJ. Kaszas K, et al. Among authors: jacobson ka. J Pharmacol Exp Ther. 2012 Jan;340(1):152-60. doi: 10.1124/jpet.111.183053. Epub 2011 Oct 17. J Pharmacol Exp Ther. 2012. PMID: 22005042 Free PMC article.

7

New paradigms in purinergic receptor ligand discovery.

Jacobson KA, Pradhan B, Wen Z, Pramanik A. Jacobson KA, et al. Neuropharmacology. 2023 Jun 1;230:109503. doi: 10.1016/j.neuropharm.2023.109503. Epub 2023 Mar 13. Neuropharmacology. 2023. PMID: 36921890 Review.

8

Corrigendum to "New paradigms in purinergic receptor ligand discovery" [Neuropharmacology 230 (2023) 109503].

Jacobson KA, Pradhan B, Wen Z, Pramanik A. Jacobson KA, et al. Neuropharmacology. 2023 Dec 15;241:109731. doi: 10.1016/j.neuropharm.2023.109731. Epub 2023 Oct 7. Neuropharmacology. 2023. PMID: 37806912 Free PMC article. No abstract available.

9

Anti-inflammatory potency of novel ecto-5'-nucleotidase/CD73 inhibitors in astrocyte culture model of neuroinflammation.

Mihajlovic K, Bukvic MA, Dragic M, Scortichini M, Jacobson KA, Nedeljkovic N. Mihajlovic K, et al. Among authors: jacobson ka. Eur J Pharmacol. 2023 Oct 5;956:175943. doi: 10.1016/j.ejphar.2023.175943. Epub 2023 Aug 2. Eur J Pharmacol. 2023. PMID: 37541364

10

Potential for developing purinergic drugs for gastrointestinal diseases.

Ochoa-Cortes F, Liñán-Rico A, Jacobson KA, Christofi FL. Ochoa-Cortes F, et al. Among authors: jacobson ka. Inflamm Bowel Dis. 2014 Jul;20(7):1259-87. doi: 10.1097/MIB.0000000000000047. Inflamm Bowel Dis. 2014. PMID: 24859298 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

834 results

Search Page